October 23, 2014 4:43 PM ET

Biotechnology

Company Overview of Iguazu Biosciences Corp.

Company Overview

Iguazu Biosciences Corp. researches, manufactures, and develops novel generation of HIV vaccines. The company uses cocktails of harmless live attenuated RNA viruses, already used as human vaccines, as vectors to express comprehensive libraries of antigens of other deadly viruses. Iguazu Biosciences Corp. was founded in 2001 and is based in Del Mar, California.

1401 Camino Del Mar

Suite 202

Del Mar, CA 92014

United States

Founded in 2001

Phone:

415-951-4720

Fax:

415-951-4660

Key Executives for Iguazu Biosciences Corp.

Chief Executive Officer
Age: 55
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Baxalta Inc. United States
Auritec Pharmaceuticals, Inc. United States
Medicinal Genomics Corporation United States
3-D Matrix, Inc. United States
Bacterial BarCodes, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Iguazu Biosciences Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.